Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelociguat + Vardenafil in Erectile Dysfunction
NCT01168817Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 2, randomised, double-blind trial of nelociguat in erectile dysfunction (ED) (3 arms), sponsored by Bayer. Primary endpoint: International Index of Erectile Function - Erectile Function subscale at 4 weeks. Started Aug 2010; status: completed.
02
Drugs
nelociguat
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT01168817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01168817.